Toomas Neuman (PhD) is an expert in molecular and cell biology and the founder of several biotechnology companies in US and Estonia. His team performed the first autologous stem cell therapy on a Parkinson's disease patient at the Cedars Sinai Medical Center (Los Angeles, CA) in 1998. He was a founder of Neurogeneration, later Celmed Biosciences (Los Angeles, CA). In 2003 Toomas and his colleagues founded Protobios Toomas Neuman is a Professor at the Tallinn University of Technology (Estonia). Next to Protobios he also founded biotechnology companies including FibroTx, Cellin Technologies and BiotaP in Estonia. Toomas Neuman is the author of more than 70 scientific publications in international journals and has presented his work at numerous scientific meetings. He is an inventor with 8 patents and 7 patent applications.